Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 May 6:12:e63605.
doi: 10.2196/63605.

The Prevalence and Incidence of Suicidal Thoughts and Behavior in a Smartphone-Delivered Treatment Trial for Body Dysmorphic Disorder: Cohort Study

Affiliations
Randomized Controlled Trial

The Prevalence and Incidence of Suicidal Thoughts and Behavior in a Smartphone-Delivered Treatment Trial for Body Dysmorphic Disorder: Cohort Study

Adam C Jaroszewski et al. JMIR Ment Health. .

Abstract

Background: People with past suicidal thoughts and behavior (STB) are often excluded from digital mental health intervention (DMHI) treatment trials. This may perpetuate barriers to care and reduce treatment generalizability, especially in populations with elevated rates of STB, such as body dysmorphic disorder (BDD). We conducted a cohort study of randomized controlled trial (RCT) participants (N=80) who received a smartphone-based cognitive behavioral therapy (CBT) treatment for BDD that allowed for most forms of past STB, except for past-month active suicidal ideation.

Objective: This study had two objectives: (1) to characterize the sample's lifetime prevalence of STB and (2) to estimate and predict STB incidence during the trial.

Methods: We completed secondary analyses on data from an RCT of smartphone-delivered CBT for BDD. The primary outcomes consisted of STB severity and suicide attempt assessed at baseline with the Columbia-Suicide Severity Rating Scale (C-SSRS) and weekly during the trial via one item from the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR item #12; 1043 observations). We computed descriptive statistics (n, %) and ran a series of bi- and multivariate linear regressions predicting STB incidence during the 3-month trial.

Results: At baseline, 40% of participants reported a lifetime history of active suicidal thoughts and 10% reported lifetime suicide attempts. During the 3-month trial, 42.5% reporting thinking about death or suicide via weekly assessment. No participants reported frequent or acute suicidal thoughts, plans, or attempts. Lifetime suicide attempt (odds ratio 11, 95% CI 2.14-59.14; P<.01) and lifetime severity of suicidal thoughts (odds ratio 1.76, 95% CI 1.21-2.77; P<.01) were significant bivariate predictors of death- or suicide-related thought incidence reported during the trial. Multivariate models including STB risk factor covariates (eg, age, and sexual orientation) modestly improved prediction of death- or suicide-related thoughts (eg, positive predictive value=0.91, negative predictive value=0.75, and area under the receiver operating characteristic curve=0.83).

Conclusions: Although some participants may think about death and suicide during a DMHI trial, it may be safe and feasible to include participants with most forms of past STB. Among other procedures, researchers should carefully select eligibility criteria, use frequent, ongoing, low-burden, and valid monitoring procedures, and implement risk mitigation protocols tailored to the presenting problem.

Keywords: adult; body dysmorphic disorder (BDD); burden; digital health; digital mental health; digital mental health intervention (DMHI); health informatics; mHealth; medication; mental health; mobile health; prevalence; risk assessment; self-harm; self-injurious; smartphone; smartphone-delivered; suicidal; suicidal thoughts and behavior; suicide; suicide prevention; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: ACJ and IS have received salary support from Koa Health (formerly Telefónica Alpha, Inc). JLG and HW have received salary support from Koa Health and are presenters for the Massachusetts General Hospital Psychiatry Academy in educational programs supported through independent medical education grants from pharmaceutical companies. Additionally, HW has a consulting agreement with Hello Therapeutics, Inc. SW is a presenter for the Massachusetts General Hospital Psychiatry Academy in educational programs supported through independent medical education grants from pharmaceutical companies. She has received royalties from Elsevier Publications, Guilford Publications, New Harbinger Publications, Springer, and Oxford University Press. SW has also received speaking honoraria from various academic institutions and foundations, including the International Obsessive Compulsive Disorder Foundation, the Tourette Association of America and the Centers for Disease Control and Prevention. In addition, she received payment from the Association for Behavioral and Cognitive Therapies for her role as Associate Editor for the journal Behavior Therapy, as well as from John Wiley and Sons, Inc for her role as Associate Editor for the journal Depression and Anxiety. SW has also received honoraria from One-Mind for her role on the PsyberGuide Scientific Advisory Board. She serves on the Scientific Advisory Board for both Koa Health, Inc and Noom, Inc. SW has received research and salary support from Koa Health, Inc and has a consulting agreement with Noom, Inc. The other authors have no disclosures.

References

    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593–602. doi: 10.1001/archpsyc.62.6.593. doi. Medline. - DOI - PubMed
    1. Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011 Jan;6(1):21–37. doi: 10.1177/1745691610393527. doi. Medline. - DOI - PubMed
    1. Patel V, Maj M, Flisher AJ, et al. Reducing the treatment gap for mental disorders: a WPA survey. World Psychiatry. 2010 Oct;9(3):169–176. doi: 10.1002/j.2051-5545.2010.tb00305.x. doi. Medline. - DOI - PMC - PubMed
    1. Wilhelm S, Weingarden H, Ladis I, et al. Cognitive-behavioral therapy in the digital age: presidential address. Behav Ther. 2020 Jan;51(1):1–14. doi: 10.1016/j.beth.2019.08.001. doi. Medline. - DOI - PMC - PubMed
    1. Rief W, Asmundson GJG, Bryant RA, et al. The future of psychological treatments: the Marburg Declaration. Clin Psychol Rev. 2024 Jun;110:102417. doi: 10.1016/j.cpr.2024.102417. doi. Medline. - DOI - PubMed

Publication types